Weight loss drugs: what do I tell patients if they ask about them?

An update on weight-loss drugs semaglutide (Wegovy) and tirzepatide (Mounjaro), who should avoid them and what the alternatives are

Authors

Institutions

Publication Details

Journal
Nursing Standard
Published
2024-12-04
DOI
https://doi.org/10.7748/ns.39.12.12.s5
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Weight loss drugs: what do I tell patients if they ask about them?

Pavan Amara
Nursing Standard
Pharmacology and Obesity Treatment
article

Weight loss drugs: what do I tell patients if they ask about them?

Pavan Amara
article en

Abstract

An update on weight-loss drugs semaglutide (Wegovy) and tirzepatide (Mounjaro), who should avoid them and what the alternatives are

Nursing StandardVol. 39(12)
World Federation of Science Journalists (CA)
Gender equality
Openalex Percentile: Top 78%
Pharmacology and Obesity Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Weight loss drugs: what do I tell patients if they ask about them? — Pavan Amara · Nursing Standard (2024) | TGRS Research Map | TGRS